Liquidia (NASDAQ:LQDA) Stock Price Breaks Below 200-Day Moving Average – Should You Sell?

Shares of Liquidia Corporation (NASDAQ:LQDA – Get Free Report) passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $55.06 and traded as low as $53.97. Liquidia shares last traded at $54.43, with a volume of 1,690,881 shares traded.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on LQDA shares. Needham & Company LLC lifted their price objective on Liquidia from $58.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, November 11th. Wells Fargo & Company increased their price target on shares of Liquidia from $33.00 to $40.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 11th. Weiss Ratings raised Liquidia from a “sell (d-)” rating to a “hold (c)” rating in a research note on Tuesday, September 22nd. Royal Bank Of Canada set a $65.00 price target on Liquidia in a research report on Thursday, October 15th. Finally, Lifesci Capital raised Liquidia from a “hold” rating to an “outperform” rating and set a $59.00 price target for the company in a report on Wednesday, October 14th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $75.23.

Check Out Our Latest Research Report on LQDA

Liquidia Price Performance

The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.96 and a current ratio of 1.02. The business has a 50 day moving average price of $47.77 and a two-hundred day moving average price of $55.06. The stock has a market cap of $4.90 billion, a PE ratio of -44.25 and a beta of 0.40.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Tuesday, November 10th. The company reported ($2.64) earnings per share for the quarter, missing analysts’ consensus estimates of $0.96 by ($3.60). The business had revenue of $225.30 million for the quarter, compared to the consensus estimate of $214.18 million. Liquidia had a positive return on equity of 264.65% and a negative net margin of 15.15%. Liquidia’s revenue for the quarter was up 314.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.04) EPS. Research analysts expect that Liquidia Corporation will post 3.36 earnings per share for the current fiscal year.

Insider Activity

In related news, CAO Dana Boyle sold 1,581 shares of the business’s stock in a transaction on Monday, October 26th. The shares were sold at an average price of $43.19, for a total value of $68,283.39. Following the sale, the chief accounting officer owned 164,028 shares in the company, valued at approximately $7,084,369.32. The trade was a 0.95% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Michael Kaseta sold 18,938 shares of the stock in a transaction on Monday, October 12th. The shares were sold at an average price of $28.48, for a total value of $539,354.24. Following the sale, the chief financial officer owned 340,148 shares in the company, valued at $9,687,415.04. The trade was a 5.27% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 358,232 shares of company stock worth $10,599,228. 25.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Liquidia

Institutional investors and hedge funds have recently modified their holdings of the stock. American Century Companies Inc. boosted its position in Liquidia by 1.0% during the 3rd quarter. American Century Companies Inc. now owns 547,673 shares of the company’s stock valued at $16,573,000 after acquiring an additional 5,542 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Liquidia by 6.7% during the 3rd quarter. Goldman Sachs Group Inc. now owns 1,023,495 shares of the company’s stock worth $30,971,000 after purchasing an additional 64,603 shares during the last quarter. WCG Wealth Advisors LLC increased its holdings in Liquidia by 13.4% in the 3rd quarter. WCG Wealth Advisors LLC now owns 38,149 shares of the company’s stock valued at $1,154,000 after purchasing an additional 4,494 shares during the last quarter. State of Tennessee Department of Treasury lifted its stake in Liquidia by 326.6% during the 3rd quarter. State of Tennessee Department of Treasury now owns 29,428 shares of the company’s stock worth $890,000 after acquiring an additional 22,529 shares in the last quarter. Finally, Jump Financial LLC purchased a new stake in shares of Liquidia during the third quarter worth $3,931,000. Institutional investors own 64.54% of the company’s stock.

Liquidia Company Profile

(Get Free Report)

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing treatments for pulmonary hypertension and other serious diseases. Its work includes inhaled therapies designed to deliver medicines to the lungs. The company’s marketed product, Yutrepia (treprostinil) inhalation powder, is approved in the United States for adults with pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Liquidia also has a pipeline of investigational therapies, including other formulations of treprostinil.

See Also

Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.